Case Report: Pelvic abscess formation secondary to the use of commercial hemostatic topical agent in an immunocompromised patient?
Crossref DOI link: https://doi.org/10.17352/jgro.000043
Published Online: 2017-07-03
Update policy: https://doi.org/10.17352/crossmark-policy
Ayala-Yáñez, R
Monzón-Vargas, M
Gómez-Meraz, Y
Version of Record valid from 2013-11-25
Accepted Manuscript valid from 2015-05-25